Lord, Abbett & Co
LAB icon

Lord, Abbett & Co’s Standard BioTools LAB Stock Holding History

Lord, Abbett & Co’s Portfolio LAB Stock Details LAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-287,967
Closed -$2.31M – 916
2016
Q3 		$2.31M Sell
287,967
-30,124
-9% -$277K 0.01% 822
2016
Q2 		$2.87M Buy
318,091
+7,817
+3% +$73.5K 0.01% 798
2016
Q1 		$2.5M Buy
310,274
+105,716
+52% +$762K 0.01% 811
2015
Q4 		$2.21M Buy
+204,558
New +$2.01M 0.01% 833
2015
Q3 		– Sell
-691,043
Closed -$16.7M – 935
2015
Q2 		$16.7M Sell
691,043
-894,290
-56% -$28.2M 0.04% 533
2015
Q1 		$66.7M Buy
1,585,333
+393,721
+33% +$15.6M 0.17% 169
2014
Q4 		$40.2M Buy
1,191,612
+440,574
+59% +$12.5M 0.1% 280
2014
Q3 		$18.4M Buy
751,038
+90,692
+14% +$2.55M 0.05% 511
2014
Q2 		$19.4M Sell
660,346
-641,512
-49% -$20.6M 0.04% 529
2014
Q1 		$57.4M Sell
1,301,858
-359,022
-22% -$15.8M 0.13% 230
2013
Q4 		$63.6M Buy
1,660,880
+746,046
+82% +$22M 0.14% 200
2013
Q3 		$20.1M Buy
914,834
+700,534
+327% +$13.8M 0.05% 521
2013
Q2 		$3.74M Buy
+214,300
New +$3.76M 0.01% 853

Other funds holding LAB

LCS
Levin Capital Strategies New York $1.49B AUM 30.44% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Lord, Abbett & Co's LAB Position: Q4 2016 in Review

Lord, Abbett & Co sold out of Standard BioTools (LAB) in Q4 2016, closing a stake of 287,967 shares — an estimated $2.31M sold.

Lord, Abbett & Co first reported a position in LAB in Q2 2013 and held it in 13 quarters. The position peaked at $66.7M in Q1 2015. 83 funds tracked by Wall St. Rank hold LAB as of Q4 2016.

  • Lord, Abbett & Co reported no remaining Standard BioTools position as of Q4 2016 after selling out during the quarter.
  • Lord, Abbett & Co sold 287,967 Standard BioTools shares in Q4 2016, an estimated $2.31M.
  • Lord, Abbett & Co first reported a position in Standard BioTools in Q2 2013 and held it in 13 quarters.
  • Lord, Abbett & Co's Standard BioTools position peaked at $66.7M in Q1 2015.
  • 83 funds tracked by Wall St. Rank held Standard BioTools as of Q4 2016.

Based on Lord, Abbett & Co's 13F filing for Q4 2016, filed 14 Feb 2017.